Harvard Bioscience, Inc. (HBIO) at a glance

Harvard Bioscience, Inc. (HBIO) is a micro-cap Healthcare company. It trades at $7.58, with a -11.9% profit margin and revenue growth of 11.1%. It does not pay a dividend. Vestovix scores it 41/100 overall. Its strongest dimension is Momentum (63/100) and its weakest is Safety (24/100). It carries above-market volatility, so expect larger swings.

Price

$7.58

Market cap

$34.5M

P/E ratio

n/a

Dividend yield

None

Beta

1.49

52-week range

$3.80 to $9.40